Sublime® Nursing Bra - Beige

Marsoni

M251S

$70.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Sublime® Nursing Bra - BeigeThe nursing T shirt bra youll reach for every day. Perfect from the first trimester to the fourth and beyond, it features contoured cups that provide a smooth silhouette under clothes and clip down access that makes breastfeeding simple. One handed clip down nursing access Crafted in Kindred Bravely's signature Sublime fabric, a seamless knit that's smooth, stretchy, and supportive, adapting to you through every stage Fixed padding for shape and

Easy Shipping

Quick Dispatch:

Your Sublime® Nursing Bra - Beige orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Sublime® Nursing Bra - Beige ships.

Need Help?
Questions about Sublime® Nursing Bra - Beige, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Sublime® Nursing Bra - Beige in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

It's not often you get to say 'perfect' about almost anything, but this is one of them. The product was a terrific price, it came in a day, was packaged perfectly, was easily removed from clever packaging, it was simple and obvious how to install, and it fir perfectly, both front and back. True OEM fit, feel, and finish. Like I sad, peeerfect for my VW Touareg. As advertised. 5-star. And I ask again, how many 5-star ratings have you given? This is my first and I'm n old guy. Been doing business on Amazon for decades.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on April 30, 2026